Variable | n = 130 |
---|---|
Age in years, mean (SD) | 61.1 (17.7) |
Female gender, n (%) | 83 (63.8) |
Area of residence | |
Urban, n (%) | 41 (31.5) |
Semiurban, n (%) | 39 (30) |
Rural, n (%) | 50 (38.5) |
Predisposing clinical conditions† | 60 (46.2) |
Immunosuppressant◇ use, n (%) | 3 (2.3) |
Malignancy, n (%) | 12 (9.2) |
HIV, n (%) | 0 |
Transplant, n (%) | 1 (0.8) |
Chronic disease*, n (%) | 39 (30) |
Trauma/burns/radiotherapy, n (%) | 3 (2.3) |
Other** | 6 (4.6) |
Not reflected in clinical history, n (%) | 2 (1.5) |
Complications†, n (%) | 31 (23.8) |
Ocular, n (%) | 11 (8.5) |
Bacterial superinfection, n (%) | 7 (5.4) |
Dysgeusia, n (%) | 4 (3.1) |
Hypoacusis, vertigo, tinnitus, n (%) | 2 (1.5) |
Dissemination, n (%) | 2 (1.5) |
Involvement of other organs, n (%) | 1 (0.8) |
Other‡, n (%) | 12 (9.2) |
Use of antiviral agents, n (%) | 119 (91.5) |
Time elapsed from symptom onset to diagnosis, days (SD) | 6.3 (5.8) |